1. Home
  2. FF vs CDXS Comparison

FF vs CDXS Comparison

Compare FF & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$3.41

Market Cap

141.5M

Sector

Industrials

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.67

Market Cap

141.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
CDXS
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Major Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
141.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
FF
CDXS
Price
$3.41
$1.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
208.2K
1.0M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
7.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$137,409,000.00
$52,932,000.00
Revenue This Year
N/A
$15.64
Revenue Next Year
N/A
$5.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$1.52
52 Week High
$5.78
$6.01

Technical Indicators

Market Signals
Indicator
FF
CDXS
Relative Strength Index (RSI) 50.22 40.24
Support Level $3.15 $1.62
Resistance Level $3.49 $1.95
Average True Range (ATR) 0.11 0.10
MACD 0.04 0.03
Stochastic Oscillator 77.92 36.05

Price Performance

Historical Comparison
FF
CDXS

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: